$Hims & Hers Health Inc.(HIMS)

1
1
Favorite

LFGP
08-23

DCA through sell put assignment, now to sell call for cashflow.

HIMS

08-23 14:35

USHims & Hers Health Inc.

Side	Price \| Filled	Realized P&L
Buy Open	45.00 100	-12.82% Holding

Hims & Hers Health Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

Top
Latest

Trade Feed Decoder
·08-23
TOP
Analysis of HIMS trade: The BUY at $45 reflects confidence in Hims & Hers' niche in telehealth and personalized wellness—a sector with growth potential amid rising demand for digital healthcare solutions. While the entry price aligns with recent volatility in growth stocks, investors might assess the company's path to profitability against competitive pressures in subscription-based health services. Position sizing isn't disclosed, but sector concentration risks in speculative health-tech names warrant consideration. The trade appears oriented toward thematic growth exposure rather than short-term catalysts. Monitoring execution on customer acquisition costs and unit economics could be critical, given the stock's sensitivity to operational milestones in a competitive market.
Reply
Like
Report

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":470604590842344,"tweetId":"470604590842344","gmtCreate":1755930967341,"gmtModify":1765209937585,"author":{"id":4192699083998182,"idStr":"4192699083998182","authorId":4192699083998182,"authorIdStr":"4192699083998182","name":"LFGP","avatar":"https://community-static.tradeup.com/news/b5dfec255d778d3a2936a9843d8ec5b0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.24","exceedPercentage":"93.10%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":169,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":126,"starInvestorOrderShareNum":374,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":77.42,"showRor":true,"investmentPhilosophy":"Invest in fundamentally strong companies while using options wheel strategy to seek regular income.","winRationPercentage":81.140351,"tradeVolumeEst":0},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$&nbsp;</a><p>DCA through sell put assignment, now to sell call for cashflow.</p></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$&nbsp;</a><p>DCA through sell put assignment, now to sell call for cashflow.</p></body></html>","text":"$Hims & Hers Health Inc.(HIMS)$ DCA through sell put assignment, now to sell call for cashflow.","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/470604590842344","repostId":0,"isVote":1,"tweetType":1,"viewCount":613,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["HIMS"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4192699083998182","orderId":"40243262384772096","kind":"TRADE","symbol":"HIMS","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/HIMS","symbolName":"Hims & Hers Health Inc.","market":"US","action":"BUY","currency":"USD","symbolLogo":"https://static.tigerbbs.com/f00f541f78cb2909963e49e74f0bf2a3","showFilledQuantity":true,"nameCN":"Hims & Hers Health Inc.","orderType":"LMT","filledQuantityFinal":100,"avgFillPrice":45,"createTime":1755930925,"filledQuantity":"100","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"Hims & Hers Health Inc.","contractExtraDescription":"HIMS","legs":[],"completedFlag":false,"orderPnl":{"openRealizedPnlPercent":0,"openUnrealizedPnlPercent":-0.1282},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":53,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":470621690151336,"commentId":"470621690151336","gmtCreate":1755935141518,"gmtModify":1755935146271,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":470604590842344,"objectIdStr":"470604590842344","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Analysis of HIMS trade: The BUY at $45 reflects confidence in Hims &amp; Hers' niche in telehealth and personalized wellness—a sector with growth potential amid rising demand for digital healthcare solutions. While the entry price aligns with recent volatility in growth stocks, investors might assess the company's path to profitability against competitive pressures in subscription-based health services. Position sizing isn't disclosed, but sector concentration risks in speculative health-tech names warrant consideration. The trade appears oriented toward thematic growth exposure rather than short-term catalysts. Monitoring execution on customer acquisition costs and unit economics could be critical, given the stock's sensitivity to operational milestones in a competitive market.","text":"Analysis of HIMS trade: The BUY at $45 reflects confidence in Hims &amp; Hers' niche in telehealth and personalized wellness—a sector with growth potential amid rising demand for digital healthcare solutions. While the entry price aligns with recent volatility in growth stocks, investors might assess the company's path to profitability against competitive pressures in subscription-based health services. Position sizing isn't disclosed, but sector concentration risks in speculative health-tech names warrant consideration. The trade appears oriented toward thematic growth exposure rather than short-term catalysts. Monitoring execution on customer acquisition costs and unit economics could be critical, given the stock's sensitivity to operational milestones in a competitive market.","html":"Analysis of HIMS trade: The BUY at $45 reflects confidence in Hims &amp; Hers' niche in telehealth and personalized wellness—a sector with growth potential amid rising demand for digital healthcare solutions. While the entry price aligns with recent volatility in growth stocks, investors might assess the company's path to profitability against competitive pressures in subscription-based health services. Position sizing isn't disclosed, but sector concentration risks in speculative health-tech names warrant consideration. The trade appears oriented toward thematic growth exposure rather than short-term catalysts. Monitoring execution on customer acquisition costs and unit economics could be critical, given the stock's sensitivity to operational milestones in a competitive market.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"hasMoreComment":true,"orderType":2}